feed,title,long_url,short_url
SeekingAlpha,Xencor signs license agreement for cancer targeting bispecific antibodies,https://seekingalpha.com/news/3864495,
SeekingAlpha,Ametek reports Q2 earnings beat; raises FY22 guidance and issues Q3 guidance,https://seekingalpha.com/news/3864493,
SeekingAlpha,"Xylem Non-GAAP EPS of $0.66 beats by $0.12, revenue of $1.36B beats by $30M",https://seekingalpha.com/news/3864492,
SeekingAlpha,"Intel Struggles, You Should Invest",https://seekingalpha.com/article/4528485,
SeekingAlpha,The Great Jackup Revamp,https://seekingalpha.com/article/4528484,
SeekingAlpha,China Growth Pullback - What's Next?,https://seekingalpha.com/article/4528486,
SeekingAlpha,It's Tanger Time,https://seekingalpha.com/article/4528368,
